These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 9393858)

  • 1. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
    Kamijo T; Zindy F; Roussel MF; Quelle DE; Downing JR; Ashmun RA; Grosveld G; Sherr CJ
    Cell; 1997 Nov; 91(5):649-59. PubMed ID: 9393858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.
    Quelle DE; Cheng M; Ashmun RA; Sherr CJ
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):669-73. PubMed ID: 9012842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.
    Carnero A; Hudson JD; Price CM; Beach DH
    Nat Cell Biol; 2000 Mar; 2(3):148-55. PubMed ID: 10707085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
    Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA
    Nature; 2001 Sep; 413(6851):86-91. PubMed ID: 11544531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties.
    Calabrò V; Parisi T; Di Cristofano A; La Mantia G
    Oncogene; 1999 Mar; 18(12):2157-62. PubMed ID: 10321741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
    Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
    Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
    Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
    Randle DH; Zindy F; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
    Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
    Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.
    Quelle DE; Zindy F; Ashmun RA; Sherr CJ
    Cell; 1995 Dec; 83(6):993-1000. PubMed ID: 8521522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
    Kamijo T; van de Kamp E; Chong MJ; Zindy F; Diehl JA; Sherr CJ; McKinnon PJ
    Cancer Res; 1999 May; 59(10):2464-9. PubMed ID: 10344759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the INK4a locus in tumor suppression and cell mortality.
    Serrano M; Lee H; Chin L; Cordon-Cardo C; Beach D; DePinho RA
    Cell; 1996 Apr; 85(1):27-37. PubMed ID: 8620534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
    Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid asymmetric evolution of a dual-coding tumor suppressor INK4a/ARF locus contradicts its function.
    Szklarczyk R; Heringa J; Pond SK; Nekrutenko A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12807-12. PubMed ID: 17652172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
    Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ARF-p53 senescence pathway in mouse and human cells.
    Wadhwa R; Sugihara T; Taira K; Kaul SC
    Histol Histopathol; 2004 Jan; 19(1):311-6. PubMed ID: 14702199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.